Nidanilimab (Anti-IL-1RAP / IL-1R3)

Catalog No.A2444        Batch: A244401

Print

Technical Data

CAS No. 2171061-85-9
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Isotype Human IgG1
Source CHO
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Purity 99%
Protein concentration 4.52mg/ml
Endotoxin Level <1EU/mg

Biological Activity

Description Nidanilimab (Anti-IL-1RAP / IL-1R3) is a fully humanized monoclonal antibody targeting IL1RAP and blocks IL1α and IL1β signaling. It also stimulates the immune system to destroy tumour cells. It can be used in treatment of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC). MW :143.56 KD.

Selleck's Nidanilimab (Anti-IL-1RAP / IL-1R3) has been cited by 1 publication

Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma [ bioRxiv, 2024, 2024.04.24.590852] PubMed: 38712234

FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.

Specific storage and handling information for each product is indicated on the product datasheet. Most Selleck products are stable under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage temperature. Short-term storage of many products are stable in the short-term at temperatures that differ from that required for long-term storage.
We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, follow the storage recommendations on the product data sheet.